News
It’s the hot-shot fix that took Hollywood — and now high school — by storm. Ozempic and other so-called “miracle” weight-loss ...
Cigna Healthcare, the health benefits division of the Cigna Group, has released a set of digital tools aimed at improving the ...
Teens are being prescribed Ozempic more than ever before — and some doctors are worried about what the trend could mean.
A recent study reveals a surge in the use of GLP-1 medications, such as Ozempic and Wegovy, among younger age groups.
Some Blue Cross and Blue Shield insurers dipped their toes into expanding coverage for blockbuster weight-loss drugs, then ...
New prescriptions for Wegovy among teenagers increased by 50% between 2023 and 2024, according to a June 3 report from healthcare data company Truveta. To analyze GLP-1 utilization trends among ...
Donation Options Search Search Search Boxes of the weight-loss medications Wegovy and Zepbound. JoNel Aleccia / AP Share Excess body weight can raise the risk of certain cancers. So researchers ...
The weight-loss injection Mounjaro (tirzepatide) leads to greater weight loss than Wegovy (semaglutide), according to UK news outlets reporting on a new study. The research found Mounjaro reduced body ...
Zepbound (tirzepatide) and Wegovy (semaglutide) are prescription drugs used for weight loss and weight management. Both drugs come as a liquid solution for injection under the skin. Zepbound and ...
Bob Powell: Well, Wegovy can no longer be used for weight loss reasons under Medicare. And here to talk with me about that is Jae Oh, author of Maximize Your Medicare. Jae, what's up? Jae Oh ...
Hims & Hers Health, Inc. HIMS announced that eligible customers can now access six months of prescription-only Wegovy at a new, affordable price. The company, via this offer, aims to make proven ...
The price of weight loss drugs is falling. Wegovy and Zepbound, which both sell for a list price of more than $1,000 a month, have long been out of reach for people without insurance or whose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results